Bio-Techne (TECH) Current Leases (2019 - 2026)
Bio-Techne (TECH) recorded quarterly Current Leases of $14.2 million in Q1 2026, up 3.44% quarter-over-quarter from $13.7 million in Q4 2025, and up 0.94% on a YoY basis from $14.0 million in Q1 2025.
Bio-Techne (TECH) Current Leases (2019 - 2026) Analysis & Trends
Bio-Techne's Current Leases history runs 8 years deep, the most recent figure standing at $14.2 million for Q1 2026.
- In Q1 2026, Current Leases rose 0.94% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (up 0.94% YoY), while the FY2025 annual figure was $14.1 million, up 9.12% from the prior year.
- Current Leases was $14.2 million for Q1 2026 at Bio-Techne, up from $13.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $14.2 million in Q1 2026 to a low of $10.7 million in Q1 2023.
- Historically, Current Leases has averaged $12.7 million across 5 years, with a median of $12.9 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Current Leases fell 9.62% in 2023, then advanced 21.03% in 2024.
- A 5-year view of Current Leases shows it stood at $11.0 million in 2022, then advanced by 15.46% to $12.7 million in 2023, then gained by 6.62% to $13.5 million in 2024, then grew by 1.47% to $13.7 million in 2025, then advanced by 3.44% to $14.2 million in 2026.
- The last three Current Leases figures came in at $14.2 million (Q1 2026), $13.7 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 14.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.18 Mn |
| Dec 31, 2025 | 13.71 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 14.10 Mn |
| Mar 31, 2025 | 14.05 Mn |
| Dec 31, 2024 | 13.51 Mn |
| Sep 30, 2024 | 13.49 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 12.67 Mn |
| Sep 30, 2023 | 12.20 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 12.12 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 11.86 Mn |
| Dec 31, 2021 | 11.81 Mn |
| Sep 30, 2021 | 12.00 Mn |
| Jun 30, 2021 | 11.60 Mn |